Abbott/$ABT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Abbott
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Ticker
$ABT
Sector
Primary listing
NYSE
Employees
115,000
Headquarters
Website
Abbott Metrics
BasicAdvanced
$183bn
34.20
$3.09
0.61
$2.44
2.38%
Price and volume
Market cap
$183bn
Beta
0.61
52-week high
$137.49
52-week low
$81.97
Average daily volume
14m
Dividend rate
$2.44
Financial strength
Current ratio
1.376
Quick ratio
0.797
Long term debt to equity
57.384
Total debt to equity
63.212
Dividend payout ratio (TTM)
78.54%
Interest coverage (TTM)
11.40%
Profitability
EBITDA (TTM)
11,867
Gross margin (TTM)
56.77%
Net profit margin (TTM)
11.65%
Operating margin (TTM)
18.63%
Effective tax rate (TTM)
27.77%
Revenue per employee (TTM)
$410,000
Management effectiveness
Return on assets (TTM)
5.33%
Return on equity (TTM)
10.58%
Valuation
Price to earnings (TTM)
34.201
Price to revenue (TTM)
3.946
Price to book
3.54
Price to tangible book (TTM)
-177.88
Price to free cash flow (TTM)
23.521
Free cash flow yield (TTM)
4.25%
Free cash flow per share (TTM)
4.494
Dividend yield (TTM)
2.31%
Forward dividend yield
2.38%
Growth
Revenue change (TTM)
8.06%
Earnings per share change (TTM)
-61.23%
3-year revenue growth (CAGR)
5.01%
10-year revenue growth (CAGR)
8.53%
3-year earnings per share growth (CAGR)
1.84%
10-year earnings per share growth (CAGR)
7.41%
3-year dividend per share growth (CAGR)
7.43%
10-year dividend per share growth (CAGR)
9.29%
What the Analysts think about Abbott
Analyst ratings (Buy, Hold, Sell) for Abbott stock.
Abbott Financial Performance
Revenues and expenses
Abbott Earnings Performance
Company profitability
Abbott News
AllArticlesVideos
Abbott investigates two separate cyber incidents, says no operations affected
Reuters·2 weeks ago
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results
Benzinga·2 weeks ago
Abbott To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.